[go: up one dir, main page]

NO20020828L - Fremgangsmåte for fremstilling av kvalitetssikret biologisk pröve og preparat inneholdende dette - Google Patents

Fremgangsmåte for fremstilling av kvalitetssikret biologisk pröve og preparat inneholdende dette

Info

Publication number
NO20020828L
NO20020828L NO20020828A NO20020828A NO20020828L NO 20020828 L NO20020828 L NO 20020828L NO 20020828 A NO20020828 A NO 20020828A NO 20020828 A NO20020828 A NO 20020828A NO 20020828 L NO20020828 L NO 20020828L
Authority
NO
Norway
Prior art keywords
preparation
biological sample
quality assured
nucleic acid
acid amplification
Prior art date
Application number
NO20020828A
Other languages
English (en)
Other versions
NO329865B1 (no
NO20020828D0 (no
Inventor
Gerold Zerlauth
Mathias Gessner
Karl Koettnitz
Patricia Gross
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of NO20020828L publication Critical patent/NO20020828L/no
Publication of NO20020828D0 publication Critical patent/NO20020828D0/no
Publication of NO329865B1 publication Critical patent/NO329865B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20020828A 1999-08-20 2002-02-20 Fremgangsmate for fremstilling av et forrad av biologiske prover som er kvalitetssikret NO329865B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0144399A AT410218B (de) 1999-08-20 1999-08-20 Verfahren zur herstellung eines qualitätsgesicherten pools biologischer proben
PCT/EP2000/007892 WO2001014593A2 (en) 1999-08-20 2000-08-14 A method for producing quality assured biological sample and composition containing the same
US09/642,633 US6649339B1 (en) 1999-08-20 2000-08-18 Method for producing a quality assured biological sample and composition containing the same

Publications (3)

Publication Number Publication Date
NO20020828L true NO20020828L (no) 2002-02-20
NO20020828D0 NO20020828D0 (no) 2002-02-20
NO329865B1 NO329865B1 (no) 2011-01-17

Family

ID=31994759

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020828A NO329865B1 (no) 1999-08-20 2002-02-20 Fremgangsmate for fremstilling av et forrad av biologiske prover som er kvalitetssikret

Country Status (10)

Country Link
US (1) US6649339B1 (no)
EP (1) EP1210465B1 (no)
JP (2) JP4578750B2 (no)
AT (2) AT410218B (no)
AU (1) AU771263B2 (no)
CA (1) CA2381969A1 (no)
DE (1) DE60011789T2 (no)
ES (1) ES2223577T3 (no)
NO (1) NO329865B1 (no)
WO (1) WO2001014593A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1421095B1 (en) 2001-08-31 2013-10-09 Gen-Probe Incorporated Assay for detection of human parvovirus b19 nucleic acid
ES2392445T3 (es) 2004-07-13 2012-12-10 Gen-Probe Incorporated Composiciones y métodos para la detección de ácido nucleico del virus de la hepatitis A
US20070212680A1 (en) * 2006-03-09 2007-09-13 Roche Molecular Systems, Inc. Safety approach for diagnostic systems
ES2945966T3 (es) * 2011-07-15 2023-07-11 Gen Probe Inc Composiciones y procedimiento para detectar ácido nucleico del parvovirus humano y ácido nucleico del virus de la hepatitis A
JP6957844B2 (ja) * 2016-08-24 2021-11-02 東洋製罐グループホールディングス株式会社 核酸増幅及び検出方法、並びに核酸増幅及び検出用溶液

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
AT389815B (de) 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4613501A (en) 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
AT390560B (de) 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
JP2971886B2 (ja) 1987-06-01 1999-11-08 ベイラー・カレツジ・オブ・メデイシン ヒトｂ‐リンパ栄養性ウイルスの免疫学的に活性なタンパク質の発現
IE72468B1 (en) 1987-07-31 1997-04-09 Univ Leland Stanford Junior Selective amplification of target polynucleotide sequences
AU622426B2 (en) 1987-12-11 1992-04-09 Abbott Laboratories Assay using template-dependent nucleic acid probe reorganization
CA1341584C (en) 1988-04-06 2008-11-18 Bruce Wallace Method of amplifying and detecting nucleic acid sequences
JP3276955B2 (ja) 1988-09-30 2002-04-22 ジーン−トラック・システムス Ｒｎａの鋳型の末端に結合したプローブ構造およびその使用方法
WO1990006995A1 (en) 1988-12-16 1990-06-28 Siska Diagnostics, Inc. Self-sustained sequence replication system
ATE151112T1 (de) 1989-12-22 1997-04-15 Hoffmann La Roche Bei hoher temperatur aktive reverse transkriptasen
EP0447984A1 (en) 1990-03-20 1991-09-25 Abbott Laboratories Hyperimmune globulin against hepatitis C virus and method for making same
AT402789B (de) 1991-03-25 1997-08-25 Immuno Ag Pharmazeutische präparation auf basis von plasmaproteinen
AT402891B (de) 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
DE69332852T2 (de) 1992-09-11 2003-12-04 F. Hoffmann-La Roche Ag, Basel Nachweis von Nukleinsäuren im Blut
EP0674531A1 (de) 1992-12-16 1995-10-04 IMMUNO Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates
AT402788B (de) 1993-08-03 1997-08-25 Immuno Ag Virussichere blutgerinnungsfaktor xiii-präparation
CA2159044A1 (en) 1994-09-26 1996-03-27 Falko-Guenter Falkner Method of quantitating nucleic acids
US5591573A (en) * 1995-04-10 1997-01-07 Alpha Therapeutic Corporation Method and system for testing blood samples
AT406019B (de) 1995-05-08 2000-01-25 Immuno Ag Verfahren zur herstellung eines arzneimittels enthaltend ein oder mehrere plasmaderivate
DE19752898A1 (de) * 1997-11-28 1999-08-05 Centeon Pharma Gmbh Verfahren zum Nachweis hoher Vierenkonzentrationen im Blutplasma und/oder Blutserum mittels der Polymerasekettenreaktion

Also Published As

Publication number Publication date
JP2003517296A (ja) 2003-05-27
WO2001014593A2 (en) 2001-03-01
AU771263B2 (en) 2004-03-18
JP4578750B2 (ja) 2010-11-10
ATE269909T1 (de) 2004-07-15
EP1210465B1 (en) 2004-06-23
CA2381969A1 (en) 2001-03-01
WO2001014593A3 (en) 2001-09-20
DE60011789D1 (de) 2004-07-29
AT410218B (de) 2003-03-25
US6649339B1 (en) 2003-11-18
ATA144399A (de) 2002-07-15
EP1210465A2 (en) 2002-06-05
DE60011789T2 (de) 2005-07-14
AU7275300A (en) 2001-03-19
JP2006087442A (ja) 2006-04-06
ES2223577T3 (es) 2005-03-01
NO329865B1 (no) 2011-01-17
NO20020828D0 (no) 2002-02-20

Similar Documents

Publication Publication Date Title
EP0542790A4 (no)
WO2001040757A3 (en) Resonant optical cavities for high-sensitivity, high-throughput biological sensors and methods
DE69103631D1 (de) Verbessertes verfahren und apparat, um biologische substanzen in lebenden zellen einzuführen.
MXPA02006145A (es) Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina.
ATE219151T1 (de) Verfahren zur quantifizierung von tumorzellen in einer körperflüssigkeit und dazu geeignete testkits
ATE21173T1 (de) Methode zur fluoreszenz-spektroskopischen bestimmung von biologisch aktiven substanzen.
DK0611157T3 (da) Fremgangsmåde til fremstilling af nukleinsyrer fra en biologisk prøve ved anvendelse af lavt pH og sur protease
NO893583L (no) Amplifikasjon og paavisning av nukleinsyresekvenser.
AR035860A1 (es) Metodos de deteccion por espectrometria de masa y cuantificacion de proteinas blanco especificas en muestras biologicas complejas
WO2001011354A3 (en) Methods for characterizing, classifying, and identifying unknowns in samples
EP1085098A3 (en) A composition for providing long term stability to cells for diagnostic testing
ATE515561T1 (de) Verfahren zum schnellen nachweis und zur zählung von mikroorganismen in säugetierzellpräparationen unter verwendung von atp-biolumineszenz
DE60210485D1 (de) Verfahren zur bestimmung des vorhandenseins von bakterien, die gegen zell-lysierende antibiotika resistent sind
ES8308928A1 (es) Metodo de detectar la presencia de adn de neisseria gonorrhoeae en material de muestra de pacientes.
DE69833660D1 (de) Nukleinsäuresonden zur detektion von candida-spezies
NO20020828L (no) Fremgangsmåte for fremstilling av kvalitetssikret biologisk pröve og preparat inneholdende dette
WO2002043779A3 (en) Use of acacia gum (arabic gum) to isolate and preserve biological material
PT1224455E (pt) Processo de separacao de um composto quimico ou biologico numa mistura de compostos similares por difusao num meio tal como um gel
EP1174520A3 (en) Method for monitoring a fermentation process using an expression array
GB2344106B (en) Eukaryotic biosensor engineered with a light emitting protein
EP1106683A3 (en) A method for providing long term stability to cells for diagnostic testing
GB0111275D0 (en) Analytical method and kit
JO1656B1 (en) New method of analysis
DK1155148T3 (da) Detektering og kvantificering af mikroorganismer under anvendelse af amplifikation og restriktionsenzymanalyse
AU3535389A (en) Method for diagnosis of infectious diseases and method of detecting and identifying microorganisms

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAXALTA INCORPORATED, CH

MK1K Patent expired